Cargando…
Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study
INTRODUCTION: Medications for opioid use disorder (MOUD) reduce illicit opioid use and overdose mortality, but effectiveness remains limited by poor treatment retention. Understanding multilevel barriers and facilitators to retention from the patient perspective can guide intervention strategies to...
Autores principales: | Poulsen, Melissa N., Asdell, Patrick B., Berrettini, Wade, McBryan, Kortney, Rahm, Alanna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912293/ https://www.ncbi.nlm.nih.gov/pubmed/36776723 http://dx.doi.org/10.1016/j.ssmmh.2022.100151 |
Ejemplares similares
-
Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse
por: Troiani, Vanessa, et al.
Publicado: (2021) -
A brief review of the genetics and pharmacogenetics of opioid use disorders
por: Berrettini, Wade
Publicado: (2017) -
Barriers and facilitators to implementing changes in opioid prescribing in rural primary care clinics
por: Parchman, Michael L., et al.
Publicado: (2020) -
Barriers, facilitators, and solutions to familial hypercholesterolemia treatment
por: Jones, Laney K., et al.
Publicado: (2020) -
Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review
por: Pijl, Em M., et al.
Publicado: (2022)